Maria Salvadó Figueras Maria Salvado has worked in the Vall d’Hebron Research Institute and the Neurology Department at Hospital Universitari Vall d’Hebron in Barcelona since 2012, where his clinical work focuses on treatment of neuromuscular disorders. Institutions of which they are part Postdoctoral researcher Peripheral Nervous System Vall Hebron Institut de Recerca Neurology General Hospital Email Maria Salvadó Figueras Email Institutions of which they are part Postdoctoral researcher Peripheral Nervous System Vall Hebron Institut de Recerca Neurology General Hospital Maria Salvado has worked in the Vall d’Hebron Research Institute and the Neurology Department at Hospital Universitari Vall d’Hebron in Barcelona since 2012, where his clinical work focuses on treatment of neuromuscular disorders.
She works as a neurologist at the Neuromuscular and Rare Diseases Unit of Vall d'Hebron Hospital and as a researcher in the Peripheral Nervous System Disease Research Laboratory (VHIR), currently led by Dr. R. Juntas-Morales. The main lines of this research group are based on the identification of new biomarkers and genetic determinants in familial and sporadic forms of amyotrophic lateral sclerosis (ALS), autoimmune myasthenia gravis (MG), and genetic-based myopathies and neuropathies. She is also one of the professionals in the European Network for Neuromuscular and Rare Diseases (EURO-NMD ERN) and the European Network for rare neurological diseases (ERN-RND). Hospital Vall d’Hebron is member of these ERNs. She is co-author of more than 20 peer-reviewed articles and in February 2020, she obtained her PhD title from the Autonomous University of Barcelona for her thesis entitled "Study of genetic factors that influence the familial and sporadic forms of myasthenia gravis autoimmune ”(Teseo, TDX). In 2013, she was awarded the Scientific Poster Award at the International Symposium for ALS (MNDA). She is a co-investigator for several grants, research projects and clinical trials, including FIS (Fondo de Investigación Sanitarias) and MINECO (Ministerio de Economía y Competitividad) grants. These grants are for studies of rare neurological diseases such as ALS, myasthenia gravis, familial amyloid polyneuropathy (Corino-Andrade disease), mitochondrial diseases and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
Projects Desarrollo e implementación de un nuevo panel de biomarcadores clínicos y moleculares para pronosticar la progresión y la supervivencia en pacientes con ELA IP: Raul Juntas Morales Collaborators: Margarita Gratacós Viñola, Maria Salvadó Figueras, Nuria Raguer Sanz, David Ovelleiro Fraile, José Manuel Vidal Taboada, Javier Joaquín Sotoca Fernández, Arnau Llauradó Gayete, Daniel Sánchez-Tejerin San José Funding agency: Instituto de Salud Carlos III Funding: 190000 Reference: PI23/00850 Duration: 01/01/2024 - 31/12/2026 GRE: Sistema Nerviòs Perifèric IP: Raul Juntas Morales Collaborators: Anna Belen Canovas Segura, Maria Salvadó Figueras, Consuelo Garcia Carmona, José Manuel Vidal Taboada, Javier Joaquín Sotoca Fernández, Arnau Llauradó Gayete, Daniel Sánchez-Tejerin San José Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 0.01 Reference: 2021 SGR 01121 Duration: 01/01/2022 - 30/06/2025 Genotipado de alta resolución de los genes HLA y análisis de su expresión en el SNC en Esclerosis Lateral Amiotrófica como factor de riesgo: Investigando la hipótesis neuroinflamatoria IP: José Manuel Vidal Taboada Collaborators: Maria Jose Herrero Mata, Maria Salvadó Figueras, Josep Gamez Carbonell, Consuelo Garcia Carmona, Arnau Llauradó Gayete Funding agency: Instituto de Salud Carlos III Funding: 117370 Reference: PI19/00593 Duration: 01/01/2020 - 30/06/2024 ANÁLISIS DE FACTORES GENETICOS DE SUSCEPTIBILIDAD Y MODIFICANTES DE FENOTIPO EN LAS FORMAS FAMILIARES Y ESPORADICAS DE MIASTENIA GRAVIS AUTOIMMUNE MEDIANTE TECNICAS DE SECUENCIACIÓN MASIVA IP: Josep Gamez Carbonell Collaborators: Gisela Gili Serrat, Maria Salvadó Figueras, Francesc Rudilla Salvador Funding agency: Instituto de Salud Carlos III Funding: 92565 Reference: PI16/01673 Duration: 01/01/2017 - 05/06/2020 Pagination Current page 1 Page 2 Next page › Last page »
